Samuel Broder
Samuel Broder · Science & Medicine
Oncologist who led development of AZT and the first antiretroviral drugs against HIV/AIDS.
1945, Poland
United States
Samuel Broder is recognized among Jewish contributors to Science & Medicine — Oncologist who led development of AZT and the first antiretroviral drugs against HIV/AIDS.
Samuel Broder is an American oncologist who, as director of the National Cancer Institute (1989–1995), led the development of zidovudine (AZT) and other early antiretroviral drugs, the first effective treatments licensed against HIV/AIDS. He was born to a Polish-Jewish family that survived the Holocaust before emigrating to Detroit; he is Jewish. His work was pivotal in transforming AIDS from a death sentence into a treatable condition.
Verify and go deeper with these external references.
Source: Jinfo.org — Jews in Biology
This page is published in seven languages from an English source. The translations are reviewed, but a mistake can still slip through. If you spot one on this profile — a wrong word, a lost date, a sentence that says something the English does not — please tell us.
Oncologist who led development of AZT and the first antiretroviral drugs against HIV/AIDS.
Source: Jinfo.org — Jews in Biology
Similar Contributors
Jerome Horwitz
Mattie Rotenberg
Albert Schatz
